ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 168 filers reported holding ANIKA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $174,675 | -71.2% | 9,376 | -59.8% | 0.00% | – |
Q2 2023 | $606,347 | +5.8% | 23,339 | +17.0% | 0.00% | – |
Q1 2023 | $572,849 | -22.3% | 19,946 | -19.9% | 0.00% | – |
Q4 2022 | $737,336 | +438.2% | 24,910 | +330.9% | 0.00% | – |
Q3 2022 | $137,000 | +24.5% | 5,781 | +16.6% | 0.00% | – |
Q2 2022 | $110,000 | -85.0% | 4,956 | -83.0% | 0.00% | – |
Q1 2022 | $732,000 | -31.3% | 29,163 | -2.1% | 0.00% | – |
Q4 2021 | $1,066,000 | +22.5% | 29,776 | +45.7% | 0.00% | – |
Q3 2021 | $870,000 | +98.6% | 20,437 | +102.0% | 0.00% | – |
Q2 2021 | $438,000 | -45.1% | 10,115 | -48.3% | 0.00% | – |
Q1 2021 | $798,000 | +1673.3% | 19,565 | +1884.3% | 0.00% | – |
Q4 2020 | $45,000 | -40.0% | 986 | -53.3% | 0.00% | – |
Q3 2020 | $75,000 | +70.5% | 2,113 | +79.8% | 0.00% | – |
Q2 2020 | $44,000 | -78.0% | 1,175 | -83.0% | 0.00% | – |
Q1 2020 | $200,000 | +2.6% | 6,916 | +83.9% | 0.00% | – |
Q4 2019 | $195,000 | -90.5% | 3,760 | -89.9% | 0.00% | -100.0% |
Q3 2019 | $2,046,000 | +173.9% | 37,284 | +102.9% | 0.00% | – |
Q2 2019 | $747,000 | -77.4% | 18,375 | -83.2% | 0.00% | -100.0% |
Q1 2019 | $3,300,000 | +37.4% | 109,132 | +52.7% | 0.00% | 0.0% |
Q4 2018 | $2,402,000 | -9.4% | 71,470 | +13.7% | 0.00% | 0.0% |
Q3 2018 | $2,651,000 | +58.9% | 62,854 | +20.6% | 0.00% | 0.0% |
Q2 2018 | $1,668,000 | +983.1% | 52,119 | +1585.1% | 0.00% | – |
Q1 2018 | $154,000 | -39.8% | 3,093 | -34.9% | 0.00% | – |
Q4 2017 | $256,000 | +73.0% | 4,753 | +85.4% | 0.00% | – |
Q3 2017 | $148,000 | +66.3% | 2,564 | +41.9% | 0.00% | – |
Q2 2017 | $89,000 | +18.7% | 1,807 | +5.0% | 0.00% | – |
Q1 2017 | $75,000 | -48.3% | 1,721 | -41.8% | 0.00% | – |
Q4 2016 | $145,000 | +2.1% | 2,959 | -0.4% | 0.00% | – |
Q3 2016 | $142,000 | +30.3% | 2,971 | +45.0% | 0.00% | – |
Q2 2016 | $109,000 | -85.3% | 2,049 | -87.7% | 0.00% | – |
Q1 2016 | $744,000 | +1081.0% | 16,636 | +896.8% | 0.00% | – |
Q4 2015 | $63,000 | -23.2% | 1,669 | -34.4% | 0.00% | – |
Q3 2015 | $82,000 | +17.1% | 2,544 | +19.5% | 0.00% | – |
Q2 2015 | $70,000 | -89.1% | 2,129 | -86.4% | 0.00% | – |
Q1 2015 | $642,000 | -37.1% | 15,609 | -37.7% | 0.00% | -100.0% |
Q4 2014 | $1,021,000 | – | 25,061 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |